Rhabdomyosarcoma as the first presentation in Neurofibromatosis Type 1: case series and review of the literature.

Child Humans Neurofibromatosis 1 / complications Cafe-au-Lait Spots / diagnosis Rhabdomyosarcoma / genetics Germ-Line Mutation
Genetics Neurofibromatosis Type 1 rhabdomyosarcoma

Journal

Pediatric hematology and oncology
ISSN: 1521-0669
Titre abrégé: Pediatr Hematol Oncol
Pays: England
ID NLM: 8700164

Informations de publication

Date de publication:
2023
Historique:
medline: 31 7 2023
pubmed: 11 1 2023
entrez: 10 1 2023
Statut: ppublish

Résumé

Neurofibromatosis Type 1 (NF1) is a neurocutaneous syndrome characterized by multiple café-au-lait macules, neurofibromas, and predisposition to malignancies, including rhabdomyosarcomas (RMS). Somatic

Identifiants

DOI: 10.1080/08880018.2022.2153951 PMID: 36625737
pubmed: 36625737
doi: 10.1080/08880018.2022.2153951
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

506-515

Auteurs

Alison M R Castle (AMR)

Department of Genetics, Children's Hospital of Eastern Ontario (CHEO), Ottawa, Canada.

Brianna Empringham (B)

Division of Hematology/Oncology, Department of Pediatrics, Children's Hospital of Eastern Ontario (CHEO), Ottawa, Canada.

Lisa M Pinto (LM)

Division of Hematology/Oncology, Department of Pediatrics, Children's Hospital of Eastern Ontario (CHEO), Ottawa, Canada.

Anita Villani (A)

Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada.

Nisha Kanwar (N)

Division of Genome Diagnostics, Department of Paediatric Laboratory Medicine and Pathobiology, The Hospital for Sick Children, Toronto, Canada.

Lesleigh S Abbott (LS)

Division of Hematology/Oncology, Department of Pediatrics, Children's Hospital of Eastern Ontario (CHEO), Ottawa, Canada.

Sarah L Sawyer (SL)

Department of Genetics, Children's Hospital of Eastern Ontario (CHEO), Ottawa, Canada.
Children's Hospital of Eastern Ontario (CHEO) Research Institute, University of Ottawa, Ottawa, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Rhabdomyosarcoma as the first presentation in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Rhabdomyosarcoma as the first presentation in...
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies génétiques congénitales › Syndromes néoplasiques héréditaires › Neurofibromatoses › Neurofibromatose de type 1 › Rhabdomyosarcoma as the first presentation in...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Manifestations cutanées › Taches café-au-lait › Rhabdomyosarcoma as the first presentation in...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu conjonctif et des tissus mous › Sarcomes › Myosarcome › Rhabdomyosarcome › Rhabdomyosarcoma as the first presentation in...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Mutation germinale › Rhabdomyosarcoma as the first presentation in...